EUVIMEDEUVIMED entdecken
EvaluationsstudieOpen Access · CC BY 4.0

Waste to worth: diagnostic accuracy of Xpert MTB/XDR on contaminated liquid cultures to salvage the detection of drug-resistant tuberculosis

Yonas Ghebrekristos iD, Erick Auma iD, Zama Mahlobo, Rouxjeane Venter, Natalie Beylis, Jay Achar, Brigitta Derendinger, Sarishna Singh, Megan Burger, Christoffel Opperman iD, Robin Warren iD, Grant Theron iD

Journal of Clinical Microbiology · 2025

DOI: 10.1128/jcm.00580-25 ↗

Kurz gefasst

Evaluationsstudie in der Zeitschrift Journal of Clinical Microbiology, 2025. Verfasst von Yonas Ghebrekristos und 11 weiteren Autor:innen. Beteiligte Einrichtung: DSI-NRF Centre of Excellence for Biomedical Tuberculosis Research and SAMRC Centre for Tuberculosis Research, Division of Molecular Biology and Human…. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Molecular Diagnostic Techniques, Tuberculosis, Multidrug-Resistant, Extensively Drug-Resistant Tuberculosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European and Developing Countries Clinical Trials Partnership, South African Medical Research Council, NIBIB NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mycobacterium Growth Indicator Tube (MGIT) 960 culture is critical for tuberculosis (TB) drug susceptibility testing (DST) but is vulnerable to contamination. We evaluated the accuracy of Xpert MTB/XDR, a molecular DST for isoniazid, fluoroquinolone, amikacin, and ethionamide, on to-be-discarded contaminated growth. Xpert MTB/XDR was applied to acid-fast-bacilli-negative, contaminated cultures from sputum from people with rifampicin-resistant TB when Xpert MTB/XDR on sputum was unsuccessful (not resistant or susceptible for all drugs), either at diagnosis (Cohort A) or during treatment monitoring (Cohort B). Future DSTs within 3 months served as a reference standard. We determined potential care cascade improvements. In Cohort A, 10% (66/650) of people had a contaminated culture; 89% (59/66) of contaminated growths were Xpert MTB/XDR TB-positive. Sensitivity and specificity for isoniazid, fluoroquinolone, amikacin, and ethionamide resistance were 100% (95% confidence interval [CI] 85, 100) and 100% (79, 100); 100% (59, 100) and 100% (89, 100); 100% (16, 100) and 100% (91, 100); and 100% (72, 100) and 96% (78, 100), respectively. In Cohort B, 22% (28/129) of people with a contaminated culture were Xpert MTB/XDR TB-positive. Of these, 57% (16/28), 7% (2/28), and 43% (12/28) were isoniazid-, fluoroquinolone-, and ethionamide-resistant (in two, one, and four people, respectively, this would be the first resistant result). In both cohorts, time-to-DST could improve by a median (IQR) of 22 (12–42) days. Xpert MTB/XDR on contaminated MGIT960 cultures had high sensitivity and specificity for DST. This approach could mitigate culture contamination’s negative effects and improve gaps in the drug-resistant TB diagnostic cascade. IMPORTANCE Culture contamination is a common impediment to drug susceptibility testing for tuberculosis, the single biggest infectious cause of death globally. Xpert MTB/XDR is a World Health Organization-recommended rapid molecular test for second-line drug resistance. We evaluated Xpert MTB/XDR on contaminated liquid culture growth that would otherwise be discarded, with the people who provided these specimens potentially lost from care cascades. By applying Xpert MTB/XDR to contaminated growth in a high-volume programmatic laboratory, we found the number of people who had second-line DST improved, as did the number of resistant cases diagnosed and time to diagnosis. Furthermore, DST information was generated in people who otherwise would have had none. This approach can therefore reduce the effect of culture contamination on tuberculosis DST, permitting earlier diagnosis and effective treatment initiation and potentially ultimately contributing to improving clinical outcomes and reducing transmission of drug-resistant TB.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycobacterium tuberculosisMolecular Diagnostic TechniquesTuberculosis, Multidrug-ResistantExtensively Drug-Resistant TuberculosisHumansSensitivity and SpecificityAntitubercular AgentsMicrobial Sensitivity TestsSputumMaleFemaleAdult

Stichwörter der Autor:innen

Xpert MTB/XDRcontaminated culturesdrug susceptibility testingtuberculosis

Substanzen

Antitubercular Agents

Autor:innen und Institutionen

  • DSI-NRF Centre of Excellence for Biomedical Tuberculosis Research and SAMRC Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch Unive…
  • National Health Laboratory Service, Greenpoint Tuberculosis Laboratory, Cape Town, South Africa.
  • Division of Medical Microbiology, Department of Pathology, University of Cape Town, Cape Town, South Africa.
  • Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden.

ORCID-Profile: Yonas Ghebrekristos, Erick Auma, Christoffel Opperman, Robin Warren, Grant Theron

Förderung

  • European and Developing Countries Clinical Trials Partnership
  • South African Medical Research Council
  • NIBIB NIH HHS
  • NIAID NIH HHS
  • NIH HHS
  • FIC NIH HHS
  • National Institutes of Health

Zitieren

APA

Ghebrekristos, Y., Auma, E., Mahlobo, Z., Venter, R., Beylis, N., Achar, J., Derendinger, B., Singh, S., Burger, M., Opperman, C., Warren, R., & Theron, G. (2025). Waste to worth: diagnostic accuracy of Xpert MTB/XDR on contaminated liquid cultures to salvage the detection of drug-resistant tuberculosis. Journal of Clinical Microbiology. https://doi.org/10.1128/jcm.00580-25

Vancouver

Ghebrekristos Y, Auma E, Mahlobo Z, Venter R, Beylis N, Achar J, et al. Waste to worth: diagnostic accuracy of Xpert MTB/XDR on contaminated liquid cultures to salvage the detection of drug-resistant tuberculosis. Journal of Clinical Microbiology. 2025. doi:10.1128/jcm.00580-25

BibTeX
@article{Ghebrekristos2025,
  author = {Ghebrekristos, Yonas and Auma, Erick and Mahlobo, Zama and Venter, Rouxjeane and Beylis, Natalie and Achar, Jay and Derendinger, Brigitta and Singh, Sarishna and Burger, Megan and Opperman, Christoffel and Warren, Robin and Theron, Grant},
  title = {Waste to worth: diagnostic accuracy of Xpert MTB/XDR on contaminated liquid cultures to salvage the detection of drug-resistant tuberculosis},
  journal = {Journal of Clinical Microbiology},
  year = {2025},
  doi = {10.1128/jcm.00580-25}
}
Kostenlos starten →